Latest papers

Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens.

Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems

Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis

Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis.

Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone.

Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.

Early recovery of CD4 T cell receptor diversity after lymphoablative conditioning and autologous CD34 cell transplantation.

Integration of modelling and simulation into the development of intravenous busulfan in paediatrics: an industrial experience.

Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma.

Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.

Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALL.

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.

The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine.

Recurrent infantile myofibromatosis: a report of conservative management and discussion of treatment strategies.

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.

The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.

Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.